for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BUZZ-Valeant Pharmaceuticals: Falls on debt offering

** Canadian drugmaker’s U.S.-listed shares down 3.7 pct at $19.74; Canadian shares slip 1.5 pct to C$19.18

** Offers $750 mln of 5.500 pct senior secured notes due 2025; offering will be additional notes and form part of existing 5.500 pct senior secured notes due 2025

** Plans to use net proceeds, along with cash, to repay portion of its outstanding series F tranche B term loan facilities due 2022

** Stock up 9.1 pct since company reported results on Nov. 7 through Friday’s close

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up